LMR Partners LLP Decreases Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

LMR Partners LLP decreased its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 31.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 263,546 shares of the health services provider's stock after selling 121,912 shares during the quarter. LMR Partners LLP owned about 0.80% of Amedisys worth $25,435,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. KBC Group NV bought a new position in shares of Amedisys during the 3rd quarter valued at approximately $63,000. Innealta Capital LLC bought a new position in Amedisys during the second quarter valued at $64,000. Covestor Ltd raised its stake in shares of Amedisys by 134.2% in the first quarter. Covestor Ltd now owns 780 shares of the health services provider's stock valued at $72,000 after acquiring an additional 447 shares during the period. Signaturefd LLC lifted its holdings in shares of Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider's stock worth $104,000 after acquiring an additional 530 shares during the last quarter. Finally, CWM LLC boosted its stake in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider's stock worth $211,000 after purchasing an additional 277 shares during the period. Institutional investors own 94.36% of the company's stock.

Amedisys Trading Down 1.1 %

Shares of NASDAQ AMED traded down $0.96 during trading hours on Monday, reaching $89.09. The stock had a trading volume of 243,438 shares, compared to its average volume of 357,413. Amedisys, Inc. has a 52-week low of $88.98 and a 52-week high of $98.95. The firm has a market cap of $2.92 billion, a price-to-earnings ratio of 35.73, a P/E/G ratio of 1.87 and a beta of 0.78. The business's fifty day moving average price is $96.04 and its two-hundred day moving average price is $95.86. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. During the same period in the previous year, the company posted $0.98 EPS. Amedisys's quarterly revenue was up 5.7% compared to the same quarter last year. Analysts expect that Amedisys, Inc. will post 4.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on AMED. Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a "buy" rating to a "hold" rating and set a $101.00 price objective on the stock. in a research report on Monday, July 29th. Cantor Fitzgerald reissued a "neutral" rating and set a $101.00 price target on shares of Amedisys in a research note on Thursday, July 25th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $100.67.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.